156 related articles for article (PubMed ID: 23614535)
1. Suppression of lymph node and lung metastases of endometrial cancer by muscle-mediated expression of soluble vascular endothelial growth factor receptor-3.
Takahashi K; Mizukami H; Saga Y; Takei Y; Urabe M; Kume A; Machida S; Fujiwara H; Suzuki M; Ozawa K
Cancer Sci; 2013 Aug; 104(8):1107-11. PubMed ID: 23614535
[TBL] [Abstract][Full Text] [Related]
2. Development of a mouse model for lymph node metastasis with endometrial cancer.
Takahashi K; Saga Y; Mizukami H; Takei Y; Urabe M; Kume A; Suzuki M; Ozawa K
Cancer Sci; 2011 Dec; 102(12):2272-7. PubMed ID: 21910784
[TBL] [Abstract][Full Text] [Related]
3. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of VEGFR-3 activation in tumor-draining lymph nodes suppresses the outgrowth of lymph node metastases in the MT-450 syngeneic rat breast cancer model.
Quagliata L; Klusmeier S; Cremers N; Pytowski B; Harvey A; Pettis RJ; Thiele W; Sleeman JP
Clin Exp Metastasis; 2014 Mar; 31(3):351-65. PubMed ID: 24379135
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.
Lin J; Lalani AS; Harding TC; Gonzalez M; Wu WW; Luan B; Tu GH; Koprivnikar K; VanRoey MJ; He Y; Alitalo K; Jooss K
Cancer Res; 2005 Aug; 65(15):6901-9. PubMed ID: 16061674
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model.
Shibata MA; Morimoto J; Shibata E; Otsuki Y
Cancer Gene Ther; 2008 Dec; 15(12):776-86. PubMed ID: 18654613
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab inhibits growth, peritoneal dissemination, and lymph node and lung metastasis of endometrial cancer, and prolongs host survival.
Takahashi K; Saga Y; Mizukami H; Takei Y; Machida S; Fujiwara H; Ozawa K; Suzuki M
Int J Oncol; 2009 Oct; 35(4):725-9. PubMed ID: 19724908
[TBL] [Abstract][Full Text] [Related]
11. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
[TBL] [Abstract][Full Text] [Related]
12. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications.
Hoshida T; Isaka N; Hagendoorn J; di Tomaso E; Chen YL; Pytowski B; Fukumura D; Padera TP; Jain RK
Cancer Res; 2006 Aug; 66(16):8065-75. PubMed ID: 16912183
[TBL] [Abstract][Full Text] [Related]
13. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.
Burton JB; Priceman SJ; Sung JL; Brakenhielm E; An DS; Pytowski B; Alitalo K; Wu L
Cancer Res; 2008 Oct; 68(19):7828-37. PubMed ID: 18829538
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
Jennbacken K; Vallbo C; Wang W; Damber JE
Prostate; 2005 Oct; 65(2):110-6. PubMed ID: 15880525
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels.
He Y; Rajantie I; Pajusola K; Jeltsch M; Holopainen T; Yla-Herttuala S; Harding T; Jooss K; Takahashi T; Alitalo K
Cancer Res; 2005 Jun; 65(11):4739-46. PubMed ID: 15930292
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.
Chen Z; Varney ML; Backora MW; Cowan K; Solheim JC; Talmadge JE; Singh RK
Cancer Res; 2005 Oct; 65(19):9004-11. PubMed ID: 16204074
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
[TBL] [Abstract][Full Text] [Related]
18. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
[TBL] [Abstract][Full Text] [Related]
19. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
